Dr. Antonio Antovski

2023 – Present

PhD Candidate in Medical Sciences (Cardiology)
Goce Delčev University, Faculty of Medical Sciences, Štip, Republic of North Macedonia

2014

Subspecialist in Cardiology
Ss. Cyril and Methodius University, Faculty of Medicine, Skopje, Republic of North Macedonia

2005

Specialist in Internal Medicine
Ss. Cyril and Methodius University, Faculty of Medicine, Skopje, Republic of North Macedonia

2004

Master’s Degree in Cardiology
Ss. Cyril and Methodius University, Faculty of Medicine, Skopje, Republic of North Macedonia

1997

Second Lieutenant – Logistics
Military Academy Mihailo Apostolski, Logistics Officers Course, Skopje

1994

Doctor of Medicine
Ss. Cyril and Methodius University, Faculty of Medicine, Skopje, Republic of North Macedonia

2026 – Present

Cardiologist at Zan Mitrev Clinic, Skopje

2024 – Present

Cardiologist – Department of Cardiology – City General Hospital “8 Septemvri”, Skopje

2023 – 2024

Acting Head – Department of Internal Medicine – City General Hospital “8 Septemvri”, Skopje

2014 – 2024

Cardiologist and Head of Department – Department of Cardiology – City General Hospital “8 Septemvri”, Skopje

2011 – 2023

Deputy Head – Department of Internal Medicine – City General Hospital “8 Septemvri”, Skopje

2011 – 2014

Internist and Head of Department – Department of Cardiology – City General Hospital “8 Septemvri”, Skopje

2005 – 2010

Internist – Department of Cardiology – Military Hospital

2000 – 2004

Resident in Internal Medicine – Department of Internal Medicine – Military Hospital

1997 – 2000

Head of Medical Service – Logistics Training Center of the Army of the Republic of Macedonia, Skopje

2012 – 2015

Principal Investigator at the center with the highest number of enrolled patients in Southeast Europe (one of 50 participating centers) in the study:

FENOPRA-III-12-1 “PART” Study
Phase III, randomized, double-blind, parallel-group study comparing the efficacy and safety of a 12-week treatment with the fixed combination of Fenofibrate 160 mg + Pravastatin 40 mg (PRAVAFENIX®) versus Atorvastatin 20 mg in patients at high risk for coronary heart disease and mixed dyslipidemia.

2016 – 2018

Principal Investigator at Center 0007MK in the clinical trial:

MARINER Study
Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thromboembolism Risk.

2023 – Present

Principal Investigator at Center 7300MK in the study:

HERMES Study
Effect of Ziltivekimab versus placebo on morbidity and mortality in patients with chronic heart failure with mildly reduced or preserved ejection fraction and systemic inflammation.

Scientific Interests

Biomarkers for prognosis in patients with advanced heart failure
Multimarker approach (Troponin I, hsCRP, NT-proBNP)

• Transthoracic echocardiography
• Carotid artery Doppler ultrasound
• Peripheral venous Doppler ultrasound
• Peripheral arterial Doppler ultrasound
• Holter monitoring of cardiac rhythm
• Ambulatory blood pressure Holter monitoring
• Cardiac stress testing
• Coronary angiography
• Percutaneous coronary angioplasty
• Carotid angiography
• Carotid artery stenting
• Peripheral angiography
• Percutaneous peripheral arterial angioplasty
• Sclerotherapy of superficial veins
• Cardiac pacemaker implantation
• Implantation of implantable cardioverter-defibrillators (ICD)
• Cardiac resynchronization therapy (CRT-P, CRT-D)

• Macedonian Medical Association
• Macedonian Society of Cardiology
• European Society of Cardiology

Antovski A., Borozanov V., Taneva B.
Brain Natriuretic Peptide in the Treatment of Chronic Heart Failure.
Mak Med Pregled, 2003; 57(3–4):192–196.

Mitrovska S., Jovanovska S., Antovski A.
Low-Molecular-Weight Heparin – A Contemporary Approach in the Treatment of Unstable Coronary Artery Disease.
Mak Med Pregled, 2003; 57(3–4):133–137.

Poster Presentations

2004 – Tuzla, Bosnia and Herzegovina
3rd International Congress of Cardiology

Prolonged Intraventricular Conduction as a Prognostic Factor in Chronic Heart Failure
Impact of Atrial Fibrillation on Mortality in Patients with Chronic Heart Failure

2004 – Ohrid, North Macedonia
7th Congress of Gastroenterohepatology

Hepatic Function as a Prognostic Marker in Chronic Heart Failure

2006 – Ohrid, North Macedonia
3rd Macedonian Congress of Cardiology

Brain Natriuretic Peptide as a Risk Assessment Marker in Chronic Heart Failure
Prolonged Intraventricular Conduction in Patients with Elevated NT-proBNP Levels and Mortality in Advanced Heart Failure
Correlation Between Ultrasonographic Heterogeneity of Carotid Plaque and Degree of Stenosis

2007 – Ohrid, North Macedonia
17th International Medical Congress

Carotid Stenosis as a Predictor of Positive Stress Test in Patients with Hyperlipidemia
Troponin I as a Prognostic Marker in Patients with Advanced Chronic Heart Failure

• English
• Serbian